Cantor Fitzgerald Reiterates Overweight on Progyny, Maintains $25 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Sarah James has reiterated an Overweight rating on Progyny (NASDAQ:PGNY) and maintained a $25 price target.
October 01, 2024 | 3:21 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cantor Fitzgerald analyst Sarah James has reiterated an Overweight rating on Progyny and maintained a $25 price target, indicating confidence in the company's stock performance.
The reiteration of an Overweight rating and a maintained price target of $25 by a reputable analyst suggests a positive outlook for Progyny's stock. This could lead to increased investor confidence and potential upward movement in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100